/mL) at a final DNA concentration of 400 ng/mL. After three days of cell growth, protein production was induced by adding 500 μM CuSO4 to the cell culture volume. Cells were left to grow for four days before the supernatant was harvested. Afterwards supernatant was centrifuged at 16,000g for 15 minutes at 4°C.
Purification of the bispecific Tand-scFvSca-1+GPIIb/IIIa and Tand-scFvSca-1+Mutant
Fast Protein Lipid Chromatography (FPLC) purification was performed in order to separate and purify proteins from the S2 cell supernatant using ion-chromatography. Immobilised Metal Ion Affinity Chromatography was used to covalently bind histidine to Sepharose chelated copper. Firstly, supernatant was filtered using 0.45 μm membrane polyvinylidene difluoride (PVDF) filter paper with a vacuum system. The cell supernatant was applied to a chelating Sepharose fast flow column (GE Healthcare) with a flow rate of 5 mL/min. After the protein had bound to the copper in the column, unspecific proteins were washed out. This was done using washing buffer containing 50 mM NaH2PO4 (Amresco) and 300 mM NaCl (SigmaAldrich) with a pH of 8. Following this, an elution process with Imidazole was performed to remove the desired protein from the column. This process was achieved by loading 50 mM NaH2PO4, 250 mM Imidazole (Merck) and 300 mM NaCl with a pH of 8. After the antibody was collected, the column was washed with 0.5 M Ethylenediaminetetraacetic acid (EDTA; SigmaAldrich) to remove the copper from the column.
Prior to further purification, the supernatant was dialyzed against PBS and filtered with 0.22 μm membrane PVDF filter paper using a vacuum system. To increase antibody purity, a second purification was performed using a BioLogic DuoFlow FPLC machine (Biorad). The filtered supernatant was applied to a 5 mL Ni-NTA Agarose Column (Life Technologies). The supernatant was then washed at a flow rate of 5 mL/min using washing buffer. Unspecific proteins were washed off the column using 50 mM NaH2PO4, 20 mM Imidazole and 300 mM NaCl. Elution was performed using 50 mM NaH2PO4, 250 mM Imidazole and 300 mM NaCl with a pH of 8. The desired fractions of antibody were collected, dialyzed against PBS at 4 °C overnight and stored at -80°C. Protein concentrations were quantified using the Pierce TM BCA Protein Assay Kit (Thermo Scientific) per the manufacturer's instructions. Figure S1 : Gating strategy to characterize PBMCs. Figure S2 : Gating strategy to characterize Sca-1 + -PBMCs. In a last step Sca-1 expression on the PBMC subpopulations was determined using the herein presented gating strategy.
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